These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24862139)

  • 21. Long-term anticoagulation for venous thromboembolism: duration of treatment and management of warfarin therapy.
    Kearon C
    Clin Chest Med; 2010 Dec; 31(4):719-30. PubMed ID: 21047578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants.
    Wharin C; Tagalakis V
    Blood Rev; 2014 Jan; 28(1):1-8. PubMed ID: 24360911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
    Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
    Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with recurrent venous thromboembolism in patients with malignant disease.
    Lin J; Proctor MC; Varma M; Greenfield LJ; Upchurch GR; Henke PK
    J Vasc Surg; 2003 May; 37(5):976-83. PubMed ID: 12756342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation.
    Barnes GD; Kanthi Y; Froehlich JB
    Vasc Med; 2015 Apr; 20(2):143-52. PubMed ID: 25832602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VTE in patients with cancer--diagnosis, prevention, and treatment.
    Lee A
    Thromb Res; 2008; 123 Suppl 1():S50-4. PubMed ID: 18824256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current criteria to determine the duration of anticoagulant therapy].
    Palareti G
    Recenti Prog Med; 2007 Dec; 98(12):603-6. PubMed ID: 18369033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer. The SWIss Venous ThromboEmbolism Registry (SWIVTER) II.
    Spirk D; Ugi J; Korte W; Husmann M; Hayoz D; Baldi T; Frauchiger B; Banyai M; Aujesky D; Baumgartner I; Kucher N
    Thromb Haemost; 2011 Jun; 105(6):962-7. PubMed ID: 21475778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
    Ay C; Pabinger I
    Thromb Res; 2012 Apr; 129 Suppl 1():S6-9. PubMed ID: 22682135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First episode and recurrent venous thromboembolism: who is identifiably at risk?
    Liem TK; Deloughery TG
    Semin Vasc Surg; 2008 Sep; 21(3):132-8. PubMed ID: 18774448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
    Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
    Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
    Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
    Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review.
    Klok FA; Kooiman J; Huisman MV; Konstantinides S; Lankeit M
    Eur Respir J; 2015 Jan; 45(1):201-10. PubMed ID: 25102964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Venous thromboembolism and cancer].
    Meyer G
    Rev Pneumol Clin; 2014; 70(1-2):91-4. PubMed ID: 24566034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulation for prevention and treatment of cancer-related venous thromboembolism.
    Barsam SJ; Patel R; Arya R
    Br J Haematol; 2013 Jun; 161(6):764-77. PubMed ID: 23560605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact and clinical significance of recurrent venous thromboembolism.
    Labropoulos N; Spentzouris G; Gasparis AP; Meissner M
    Br J Surg; 2010 Jul; 97(7):989-99. PubMed ID: 20632262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term treatment of venous thromboembolism].
    Meyer G; Couturaud F
    Rev Prat; 2015 Feb; 65(2):208-13. PubMed ID: 25939225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
    Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M
    Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unprovoked venous thromboembolism: Short term or indefinite anticoagulation? Balancing long-term risk and benefit.
    Rodger M; Carrier M; Gandara E; Le Gal G
    Blood Rev; 2010; 24(4-5):171-8. PubMed ID: 20633967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term.
    de Jong PG; Coppens M; Middeldorp S
    Br J Haematol; 2012 Aug; 158(4):433-41. PubMed ID: 22734929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.